Toronto, Feb. 23, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce today the closing of a $1.022 million round of private equity financing (the “Offering”) via the sale of common shares.
The net proceeds raised from the Offering are intended to be used for further development of the Company’s facility, equipment, and general corporate purposes.
“We thank our investors for joining us in the quality assurance segment of the Cannabis sector,” President Thomas Fraleigh said upon close. “These funds will be used for our facility build-out and licensed dealer application. Congratulations to the whole team for closing this out, we now look forward to delivering.”
About Vivariant Laboratories Inc.
Vivariant is a private cannabis testing company focused on servicing Canadian Cannabis cultivators and processors with laboratory testing services in order to meet Health Canada’s batch testing requirements. The company is based in Mississauga, Ontario. The company plans to file for a Licensed Dealer (“LD”) permit in Q2 2018 which will allow it to receive and analyze cannabis samples as a service.